Arpin deficiency increases actomyosin contractility and vascular permeability

Armando Montoya-García,Idaira M Guerrero-Fonseca,Sandra D Chánez-Paredes,Karina B Hernández-Almaraz,Iliana I León-Vega,Angélica Silva-Olivares,Abigail Bentazos,Mónica Mondragón-Castelán,Ricardo Mondragón-Flores,Citlaltepetl Salinas-Lara,Hilda Vargas-Robles,Michael Schnoor
DOI: https://doi.org/10.7554/elife.90692
IF: 7.7
2024-09-20
eLife
Abstract:Arpin was discovered as an inhibitor of the Arp2/3 complex localized at the lamellipodial tip of fibroblasts, where it regulated migration steering. Recently, we showed that arpin stabilizes the epithelial barrier in an Arp2/3-dependent manner. However, the expression and functions of arpin in endothelial cells (EC) have not yet been described. Arpin mRNA and protein are expressed in EC and downregulated by pro-inflammatory cytokines. Arpin depletion in Human Umbilical Vein Endothelial Cells causes the formation of actomyosin stress fibers leading to increased permeability in an Arp2/3-independent manner. Instead, inhibitors of ROCK1 and ZIPK, kinases involved in the generation of stress fibers, normalize the loss-of-arpin effects on actin filaments and permeability. Arpin-deficient mice are viable but show a characteristic vascular phenotype in the lung including edema, microhemorrhage, and vascular congestion, increased F-actin levels, and vascular permeability. Our data show that, apart from being an Arp2/3 inhibitor, arpin is also a regulator of actomyosin contractility and endothelial barrier integrity.
biology
What problem does this paper attempt to address?